A 6-week, Double-blind, Randomized, Parallel-group, International, Multi-center, Phase III Study Comparing the Efficacy and Safety of Sustained-Release and Immediate-Release Quetiapine Fumarate (SEROQUEL) to PLacebo in the Treatment of Agitation Associated with Alzheimer's Dementia in Elderly Residents of Long-term Care Facilities.

Study identifier:D1444C00148

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A 6-week, Double-blind, Randomized, Parallel-group, International, Multi-center, Phase III Study Comparing the Efficacy and Safety of Sustained-Release and Immediate-Release Quetiapine Fumarate (SEROQUEL) to PLacebo in the Treatment of Agitation Associated with Alzheimer's Dementia in Elderly Residents of Long-term Care Facilities.

Medical condition

schizophrenia

Phase

Phase 3

Healthy volunteers

Study drug

Sex

Actual Enrollment

Study type

Interventional

Age

Date

Study Start Date: 01 Jan 1971

Primary Completion Date: -

Study Completion Date: -

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Collaborators

Inclusion and exclusion criteria

No locations available

Arms	Assigned Interventions

Documents available

Trial Results Summaries
Available here